Nektar Therapeutics (NKTR) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $200000.0.
- Nektar Therapeutics' Receivables - Net changed N/A to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $200000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is 7985.29% down from last year.
- Per Nektar Therapeutics' latest filing, its Receivables - Net stood at $200000.0 for Q3 2025.
- In the past 5 years, Nektar Therapeutics' Receivables - Net ranged from a high of $30.2 million in Q1 2022 and a low of $200000.0 during Q3 2025
- Its 5-year average for Receivables - Net is $12.0 million, with a median of $6.0 million in 2022.
- In the last 5 years, Nektar Therapeutics' Receivables - Net crashed by 9008.93% in 2023 and then skyrocketed by 2076.79% in 2024.
- Nektar Therapeutics' Receivables - Net (Quarter) stood at $22.5 million in 2021, then tumbled by 73.41% to $6.0 million in 2022, then plummeted by 79.85% to $1.2 million in 2023, then fell by 0.75% to $1.2 million in 2024, then tumbled by 83.28% to $200000.0 in 2025.
- Its Receivables - Net stands at $200000.0 for Q3 2025, versus $1.2 million for Q2 2024 and $3.6 million for Q1 2024.